Aconitase 2 the rescue: A safeguard against excess mitochondrial citrate
Molecular Cell · 2026-05 · 86 (9) · 1595-1597
DOI: 10.1016/j.molcel.2026.04.010 ↗Kurz gefasst
Kommentar in der Zeitschrift Molecular Cell, 2026-05. Verfasst von Edrees H Rashan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Koch Institute for Integrative Cancer Research and Department of Biology at MIT, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Aconitate Hydratase, Mitochondria, Citric Acid. Die Arbeit nennt 10 Literaturangaben. Gefördert von: National Institutes of Health National Cancer Institute, Ludwig Center at Harvard, Massachusetts Institute of Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Koch Institute for Integrative Cancer Research and Department of Biology at MIT, Cambridge, MA 02139, USA.
- Koch Institute for Integrative Cancer Research and Department of Biology at MIT, Cambridge, MA 02139, USA; Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: mvh@mit.edu.
Förderung
- National Institutes of Health National Cancer Institute
- Ludwig Center at Harvard
- Massachusetts Institute of Technology
Zitieren
APA
Rashan, E. H., D'Halleweyn, S., & Vander Heiden, M. G. (2026). Aconitase 2 the rescue: A safeguard against excess mitochondrial citrate. Molecular Cell, 86(9), 1595-1597. https://doi.org/10.1016/j.molcel.2026.04.010
Vancouver
Rashan EH, D'Halleweyn S, Vander Heiden MG. Aconitase 2 the rescue: A safeguard against excess mitochondrial citrate. Molecular Cell. 2026;86(9):1595-1597. doi:10.1016/j.molcel.2026.04.010
BibTeX
@article{Rashan2026,
author = {Rashan, Edrees H and D'Halleweyn, Sophie and Vander Heiden, Matthew G},
title = {Aconitase 2 the rescue: A safeguard against excess mitochondrial citrate},
journal = {Molecular Cell},
year = {2026},
volume = {86},
number = {9},
pages = {1595--1597},
doi = {10.1016/j.molcel.2026.04.010}
}
EUVIMED